Pfizer Inc has applied for approval from Japan's health ministry to use COVID-19 vaccines on children aged 5 to 11, it said in a statement released on Wednesday.
Pfizer's Comirnaty vaccine, developed in partnership with BioNTech, was the first COVID-19 vaccine approved for Japan's general public in February. COVID-19 vaccines developed by Moderna and AstraZeneca have since been approved.
Pfizer's vaccine is currently being offered to those aged 12 and above. If approved by the health ministry, it will be the first to be administered to children under 11 in Japan.
About 74 per cent of the population is now fully vaccinated, according to broadcaster NHK, and the government is widely expected to start administering booster shots by year-end.
Trump says he does not need China's help to end Iran war
10 islanders flown to UK for precautionary isolation after hantavirus outbreak
US war in Iran has cost $29 billion so far, Pentagon says
At Temple of Heaven summit, Trump and Xi will seek a good harvest
Peace deal hopes fade after Trump rejects Iran proposal
Protests erupt after key college entrance test cancelled in India
UK's Starmer defies calls to quit, says he is getting on with governing
New Israeli law sets military tribunal for those linked to October 7 attack
